High-throughput sequencing (HTS) is transforming recombinant adeno-associated virus (rAAV) characterization, and Viralgen's latest poster showcases cutting-edge methodologies for deeper insights into rAAV products. By enhancing sensitivity and accuracy, these innovations ensure improved quality control and better therapeutic outcomes.

Key Highlights:

Comprehensive Analysis: HTS enables precise evaluation of key quality attributes, including sequence purity, integrity, and identity.
Advanced Methodology: The poster details techniques like spiking experiments and bioinformatics workflows to detect and quantify non-payload sequences.
Future Applications: Viralgen is paving the way for integrating HTS into routine analytics, ensuring consistency and scalability in rAAV production.

This work demonstrates how HTS can empower researchers to optimize rAAV therapies, offering unparalleled insights into product quality.